This is a Validated Antibody Database (VAD) review about human SAMD9L, based on 3 published articles (read how Labome selects the articles), using SAMD9L antibody in all methods. It is aimed to help Labome visitors find the most suited SAMD9L antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SAMD9L synonym: ATXPC; C7orf6; DRIF2; UEF1; sterile alpha motif domain-containing protein 9-like; SAM domain-containing protein 9-like

Sigma-Aldrich
rabbit polyclonal
  • western blot; human; loading ...; fig 1b
In order to study M062-dependent mechanisms that inhibit human SAMD9-associated antiviral function, Sigma-Aldrich SAMD9L antibody (Sigma, HPA019465) was used in western blot on human samples (fig 1b). Virology (2017) ncbi
rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 4b
In order to elucidate pathways in pancreatic ductal adenocarcinoma involved in vesicular stomatitis virus resistance, Sigma-Aldrich SAMD9L antibody (Sigma, HPA019461) was used in western blot on human samples at 1:500 (fig 4b). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 1
In order to develop and use a high-throughput, in vivo strategy to determine which alterations are loss of function in tumor growth suppressors using bladder cancer samples, Sigma-Aldrich SAMD9L antibody (Sigma, HPA019461) was used in western blot on human samples (fig 1). Mol Cancer Res (2015) ncbi
Articles Reviewed
  1. Nounamo B, Li Y, O Byrne P, Kearney A, Khan A, Liu J. An interaction domain in human SAMD9 is essential for myxoma virus host-range determinant M062 antagonism of host anti-viral function. Virology. 2017;503:94-102 pubmed publisher
  2. Hastie E, Cataldi M, Moerdyk Schauwecker M, Felt S, Steuerwald N, Grdzelishvili V. Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Oncotarget. 2016;7:61601-61618 pubmed publisher
  3. Hensel J, Duex J, Owens C, Dancik G, Edwards M, Frierson H, et al. Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors. Mol Cancer Res. 2015;13:1306-15 pubmed publisher